Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
Matsuoka H, Clark K, Fazekas B, Oyamada S, Brown L, Ishiki H, Matsuda Y, Hasuo H, Ariyoshi K, Lee J, Le B, Allcroft P, Kochovska S, Fujiwara N, Miyaji T, Lovell M, Agar M, Yamaguchi T, Satomi E, Iwase S, Phillips J, Koyama A, Currow DC. Matsuoka H, et al. Among authors: allcroft p. BMJ Open. 2022 Feb 7;12(2):e050182. doi: 10.1136/bmjopen-2021-050182. BMJ Open. 2022. PMID: 35131817 Free PMC article.
Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.
Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, Briffa M, Johnson MJ, Abernethy AP. Currow DC, et al. Among authors: allcroft p. J Pain Symptom Manage. 2011 Sep;42(3):388-99. doi: 10.1016/j.jpainsymman.2010.11.021. Epub 2011 Mar 31. J Pain Symptom Manage. 2011. PMID: 21458217 Free article. Clinical Trial.
Chronic refractory dyspnoea--evidence based management.
Wiseman R, Rowett D, Allcroft P, Abernethy A, Currow DC. Wiseman R, et al. Among authors: allcroft p. Aust Fam Physician. 2013 Mar;42(3):137-40. Aust Fam Physician. 2013. PMID: 23529525 Free article. Review.
A Randomized, Double-Blind, Multisite, Pilot, Placebo-Controlled Trial of Regular, Low-Dose Morphine on Outcomes of Pulmonary Rehabilitation in COPD.
Kochovska S, Fazekas B, Hensley M, Wheatley J, Allcroft P, Currow DC. Kochovska S, et al. Among authors: allcroft p. J Pain Symptom Manage. 2019 Nov;58(5):e7-e9. doi: 10.1016/j.jpainsymman.2019.07.026. Epub 2019 Aug 9. J Pain Symptom Manage. 2019. PMID: 31404644 Free article. Clinical Trial. No abstract available.
Isolating peripheral effects of endogenous opioids in modulating exertional breathlessness in people with moderate or severe COPD: a randomised controlled trial.
Currow DC, Hunt T, Louw S, Eckert D, Allcroft P, To THM, Greene A, Krajnik M, Mahler D, Ekström M. Currow DC, et al. Among authors: allcroft p. ERJ Open Res. 2019 Dec 23;5(4):00153-2019. doi: 10.1183/23120541.00153-2019. eCollection 2019 Oct. ERJ Open Res. 2019. PMID: 31886161 Free PMC article.
Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide.
McCaffrey N, Asser T, Fazekas B, Muircroft W, Agar M, Clark K, Eckermann S, Lee J, Joshi R, Allcroft P, Sheehan C, Currow DC. McCaffrey N, et al. Among authors: allcroft p. BMC Cancer. 2020 Oct 31;20(1):1050. doi: 10.1186/s12885-020-07549-y. BMC Cancer. 2020. PMID: 33129304 Free PMC article. Clinical Trial.
Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial.
Ekström M, Ferreira D, Chang S, Louw S, Johnson MJ, Eckert DJ, Fazekas B, Clark KJ, Agar MR, Currow DC; Australian National Palliative Care Clinical Studies Collaborative. Ekström M, et al. JAMA. 2022 Nov 22;328(20):2022-2032. doi: 10.1001/jama.2022.20206. JAMA. 2022. PMID: 36413230 Free PMC article. Clinical Trial.
19 results